Quality assured in our Cancer Clinical Trials

Back to NEWS

MedSIR’s International Trial Lead, Salvador Ribas, will be a guest speaker at the upcoming “XXV CONGRESS OF THE SOCIEDAD ESPAÑOLA DE GARANTÍA DE CALIDAD EN INVESTIGACIÓN”, which will take place on October 19th and 20th, 2017 in our beautiful hometown of Barcelona.

His talk will touch upon the International Conference of Harmonization’s Good Clinical Practice E6 (Revision 2 (R2)) and its impact on study sponsor responsibilities with regards to quality management (check the complete program).

R2 has been enforced since June 14th of this year and plays the role of increasing the efficiency in the design and development of clinical trials and guaranteeing the correct use of new technologies applied to clinical research. Salvador will especially focus on the changes introduced in terms of quality management and their impact on the everyday activities of the study sponsor.

We at MedSIR are proud to have on board such a high-level colleague such as Salvador to understand and implement the complex issues regarding the efficient carrying out of clinical trials.

For more information please check out the Congress Brochure at www.segcib.org or directly contact us at info@medsir.org

Share (and comment) this content

Back to NEWS